Silvercrest Asset Management Group LLC Reduces Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Silvercrest Asset Management Group LLC lessened its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 13.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 25,305 shares of the company's stock after selling 4,100 shares during the period. Silvercrest Asset Management Group LLC's holdings in Henry Schein were worth $1,751,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Rafferty Asset Management LLC lifted its position in Henry Schein by 10.1% in the fourth quarter. Rafferty Asset Management LLC now owns 14,144 shares of the company's stock worth $979,000 after purchasing an additional 1,293 shares during the period. ProShare Advisors LLC increased its position in Henry Schein by 10.2% in the fourth quarter. ProShare Advisors LLC now owns 19,102 shares of the company's stock worth $1,322,000 after purchasing an additional 1,765 shares during the period. Quantinno Capital Management LP increased its position in Henry Schein by 50.1% in the fourth quarter. Quantinno Capital Management LP now owns 87,873 shares of the company's stock worth $6,081,000 after purchasing an additional 29,340 shares during the period. Mufg Securities Americas Inc. acquired a new position in shares of Henry Schein during the 4th quarter worth about $127,000. Finally, Man Group plc grew its position in shares of Henry Schein by 550.3% during the 4th quarter. Man Group plc now owns 359,927 shares of the company's stock worth $24,907,000 after buying an additional 304,580 shares during the period. 96.62% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the business's stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares of the company's stock, valued at approximately $4,460,251.20. The trade was a 6.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the transaction, the director now directly owns 24,805 shares in the company, valued at approximately $1,762,147.20. This represents a 9.50% decrease in their position. The disclosure for this sale can be found here. 1.08% of the stock is currently owned by corporate insiders.

Henry Schein Trading Down 1.0%

HSIC stock traded down $0.75 during mid-day trading on Thursday, reaching $71.33. The company's stock had a trading volume of 1,471,264 shares, compared to its average volume of 1,654,697. The company has a market cap of $8.68 billion, a price-to-earnings ratio of 29.35, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87. The business's 50 day moving average price is $67.46 and its 200 day moving average price is $71.49. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Monday, May 5th. The company reported $1.15 EPS for the quarter, beating the consensus estimate of $1.11 by $0.04. The firm had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company's quarterly revenue was down .1% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.10 earnings per share. On average, equities research analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Barrington Research cut their price objective on Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a report on Tuesday, May 6th. Wells Fargo & Company decreased their target price on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Jefferies Financial Group increased their price target on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research note on Thursday, January 23rd. Piper Sandler decreased their price objective on Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a report on Wednesday, April 30th. Finally, Wall Street Zen downgraded Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Six research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, Henry Schein presently has an average rating of "Moderate Buy" and a consensus price target of $79.30.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.